The safety and efficacy of racanisodamine on form-deprivation in guinea pigs

YANG Ying,ZHOU Xing-tao,LI Tao,LIU Hong
DOI: https://doi.org/10.3969/j.issn.1671-2420.2011.05.001
2011-01-01
Abstract:Objective To investigate the safety and efficacy of 10% racanisodamine on form-deprivation in guinea pigs.Methods Thirty guinea pigs aged from 2 to 3 weeks were randomly divided into 3 groups(n=10).Form-deprivation models were established in right eyes with translucent membranes while the left eyes were treated as control.Group A was form-deprivation with intravitreal injection of 20 μL 10% racanisodamine for one time.Group B was form-deprivation with intravitreal injection of 20 μL saline for one time.Group C was form-deprivation group.All animals were raised in 500 lx white light environment,with the lighting period of 12 h a day.Axial length,anterior chamber depth and lens thickness was measured by ultrasound,then the vitreous length was calculated.Refraction was measured by retino-scopy.Measurements were carried out before and 2 weeks after intervention and the difference between right and left eye was evaluated to eliminate the intergroup disparity during growing.Hematoxylin eosin staining was performed to observe the microstructure of eyes under microscope.Results There was no significant difference in the baseline value of biometric measurements(P>0.05).The difference in axial and vitreous length between right and left eye was significantly smaller in group A than in the other two groups(P<0.05).The difference in vitreous length was significantly correlated to that in axial length(P<0.05).No significant difference was found in refraction,lens thickness or anterior chamber depth between bilateral eyes among the groups(P>0.05).No toxic change in retina,sclera or choroid was found after racanisodamine injection.Conclusions 10% racanisodamine may prevent the axial elongation of form-deprivation myopia in guinea pigs,mainly through the inhibition of vitreous length elongation.No toxic change was found after intravitreal injection of 10% racanisodamine.
What problem does this paper attempt to address?